Circulating microRNA profile unveils mechanisms of action of acitretin for psoriasis vulgaris.
Sign Up to like & getrecommendations! Published in 2021 at "Bioengineered"
DOI: 10.1080/21655979.2021.1925205
Abstract: Psoriasis vulgaris is a common chronic and recurrent inflammatory skin disease. In clinical practice, acitretin is the first-line treatment drug for psoriasis vulgaris. MicroRNAs (miRNAs) play a vital role in the initiation and development of… read more here.
Keywords: psoriasis; acitretin treatment; psoriasis vulgaris;